Nanobiotix (NBTX) was held by 28 institutions as of Q3 2026, with a combined reported value of $197M (−9.4% from the previous quarter). The largest holder was Johnson & Johnson, reporting $175M — 89.0% of the total. The ten largest holders together account for 99.9% of the reported value. The holder count stood at 12 in Q4 2020; this ledger now covers 24 quarters of filings.
$26.90
Latest close · 2026-11-18
$31.16
At quarter-end · 2026-09-30
−13.7%
Change since quarter-end
$171M
Reported position at latest close (est.)
Closing price (reference) — End-of-day closing prices, shown for reference only — not real-time quotes. Price source: Yahoo Finance, end-of-day data.
Conviction since 2013
Aggregate reported value (bars) against the number of institutions holding (line).
The holders
Top 28 of 28 institutions, ranked by reported value. Share change is versus the manager’s previous filing.
Source: Form 13F filings via SEC EDGAR. Positions as of Sep 30, 2026. Options (put/call) are excluded from share counts.
Major holders — Schedule 13D/G
Beneficial-ownership filings under Schedule 13D/G; the latest filing per holder is shown. Shares and percentages are as stated on the filing cover — a dash means the cover did not state the figure. Coverage: filings dated Jan 2, 2024 to Nov 18, 2026; this index is still being built and is updated daily.